NanoViricides (NNVC) Competitors $1.44 -0.03 (-1.70%) Closing price 09/22/2025 03:59 PM EasternExtended Trading$1.47 +0.02 (+1.45%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NNVC vs. STTK, CRDL, JMAC, ALTS, OVID, CNTB, QNCX, HYPD, ATRA, and IFRXShould you be buying NanoViricides stock or one of its competitors? The main competitors of NanoViricides include Shattuck Labs (STTK), Cardiol Therapeutics (CRDL), Maxpro Capital Acquisition (JMAC), ALT5 Sigma (ALTS), Ovid Therapeutics (OVID), Connect Biopharma (CNTB), Quince Therapeutics (QNCX), Hyperion DeFi (HYPD), Atara Biotherapeutics (ATRA), and InflaRx (IFRX). These companies are all part of the "pharmaceutical products" industry. NanoViricides vs. Its Competitors Shattuck Labs Cardiol Therapeutics Maxpro Capital Acquisition ALT5 Sigma Ovid Therapeutics Connect Biopharma Quince Therapeutics Hyperion DeFi Atara Biotherapeutics InflaRx Shattuck Labs (NASDAQ:STTK) and NanoViricides (NYSE:NNVC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and institutional ownership. Do analysts recommend STTK or NNVC? Shattuck Labs presently has a consensus target price of $4.00, suggesting a potential upside of 63.27%. Given Shattuck Labs' stronger consensus rating and higher probable upside, analysts plainly believe Shattuck Labs is more favorable than NanoViricides.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shattuck Labs 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 2.86NanoViricides 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is STTK or NNVC more profitable? Shattuck Labs' return on equity of -81.80% beat NanoViricides' return on equity.Company Net Margins Return on Equity Return on Assets Shattuck LabsN/A -81.80% -71.46% NanoViricides N/A -87.90%-78.69% Which has more volatility and risk, STTK or NNVC? Shattuck Labs has a beta of 1.64, meaning that its share price is 64% more volatile than the S&P 500. Comparatively, NanoViricides has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500. Does the media favor STTK or NNVC? In the previous week, Shattuck Labs had 3 more articles in the media than NanoViricides. MarketBeat recorded 3 mentions for Shattuck Labs and 0 mentions for NanoViricides. Shattuck Labs' average media sentiment score of 0.81 beat NanoViricides' score of 0.00 indicating that Shattuck Labs is being referred to more favorably in the media. Company Overall Sentiment Shattuck Labs Positive NanoViricides Neutral Do insiders & institutionals hold more shares of STTK or NNVC? 58.7% of Shattuck Labs shares are owned by institutional investors. Comparatively, 10.3% of NanoViricides shares are owned by institutional investors. 12.0% of Shattuck Labs shares are owned by insiders. Comparatively, 4.6% of NanoViricides shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has stronger earnings & valuation, STTK or NNVC? NanoViricides has lower revenue, but higher earnings than Shattuck Labs. NanoViricides is trading at a lower price-to-earnings ratio than Shattuck Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioShattuck Labs$5.72M20.52-$75.41M-$1.21-2.02NanoViricidesN/AN/A-$8.29M-$0.70-2.06 SummaryShattuck Labs beats NanoViricides on 12 of the 15 factors compared between the two stocks. Get NanoViricides News Delivered to You Automatically Sign up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NNVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NNVC vs. The Competition Export to ExcelMetricNanoViricidesPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$23.22M$865.14M$5.79B$21.65BDividend YieldN/A4.84%5.61%3.50%P/E Ratio-2.011.17348.8630.23Price / SalesN/A25.98555.4058.72Price / CashN/A17.6526.0118.30Price / Book2.196.4915.994.66Net Income-$8.29M-$3.95M$3.29B$1.00B7 Day Performance-0.34%-0.22%200.40%1.11%1 Month Performance0.35%6.00%184.31%2.95%1 Year Performance-6.17%22.53%331.44%15.18% NanoViricides Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NNVCNanoViricides0.0975 of 5 stars$1.45-1.7%N/A-8.0%$23.22MN/A-2.0120STTKShattuck Labs3.9095 of 5 stars$1.79-6.8%$4.00+123.5%-34.5%$91.97M$5.72M-1.48100CRDLCardiol Therapeutics2.8627 of 5 stars$1.08+0.9%$8.00+640.7%-51.7%$91.96MN/A-3.1820News CoveragePositive NewsAnalyst RevisionJMACMaxpro Capital AcquisitionN/A$6.83+8.9%N/AN/A$91.71MN/A0.002,021ALTSALT5 Sigma0.0385 of 5 stars$3.92-6.2%N/A+85.7%$90.33M$12.53M0.00170OVIDOvid Therapeutics4.2166 of 5 stars$1.28+1.6%$3.10+142.2%+12.2%$89.60M$570K-2.4260CNTBConnect Biopharma3.6682 of 5 stars$1.60+2.6%$7.00+337.5%+28.5%$86.93M$26.03M0.00110Gap UpQNCXQuince Therapeutics2.9081 of 5 stars$1.60flat$8.14+408.9%+87.2%$85.94MN/A-1.4760HYPDHyperion DeFi0.5182 of 5 stars$11.56-22.8%$2.00-82.7%-74.6%$85.31M$60K-0.2040Gap DownHigh Trading VolumeATRAAtara Biotherapeutics4.5814 of 5 stars$11.94-1.5%$21.00+75.9%+57.9%$85.12M$128.94M-27.77330Positive NewsIFRXInflaRx3.2459 of 5 stars$1.23-2.4%$6.20+404.1%-12.9%$84.59M$180K-1.5460Positive News Related Companies and Tools Related Companies Shattuck Labs Alternatives Cardiol Therapeutics Alternatives Maxpro Capital Acquisition Alternatives ALT5 Sigma Alternatives Ovid Therapeutics Alternatives Connect Biopharma Alternatives Quince Therapeutics Alternatives Hyperion DeFi Alternatives Atara Biotherapeutics Alternatives InflaRx Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NNVC) was last updated on 9/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoViricides, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoViricides With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NNVC Stock Alerts